Effects of nilvadipine, a calcium antagonist, on intimal thickness of vascular grafting in cholesterol-fed rabbits
- 21 Downloads
The effects of nilvadipine on intimal thickness in expanded poly-tetrafluoroethylene grafts were examined in 21 rabbits undergoing infrarenal aorta reconstruction. Seven rabbits received commercial rabbit chow (control group), seven, a regular diet supplemented with 1% cholesterol (cholesterol group); and seven, the cholesterol diet with 98.9% pure nilvadipine 1 mg/kg/day (nilvadipine group). Grafts were harvested 3 months after surgery for histologic examination. Intimal thickness at the proximal and distal anastomosis was, respectively, 225±76 and 273±110 m in the control group, 525±236 and 600±250 m in the cholesterol group, and 284±94 and 241±86 m in the nilvadipine group. Intimal thickness in the cholesterol group was significantly greater than in the nilvadipine group (p<0.01). The smooth muscle cell values in the intima at the proximal and distal anastomosis were, respectively, 10.6±3.6 and 12.6±3.2 %Extinction (%E) in the control group, 15.5±4.0 and 16.1±4.5 %E in the cholesterol group, and 9.1±3.1 and 9.6±2.1 %E in the nilvadipine group. The smooth muscle cell value in the intima of the cholesterol group was greater than that of the nilvadipine group (p<0.01). These data suggest that nilvadipine significantly reduces the degree of intimal thickness in expanded polytetrafluoroethylene grafts in cholesterol-fed rabbits, and that this effect is due to inhibition of smooth muscle cell migration and proliferation.
KeywordsCholesterol Smooth Muscle Cell Calcium Antagonist Cholesterol Diet Vascular Grafting
Unable to display preview. Download preview PDF.
- 4.El-Sanadiki MN, Cross KS, Mikt EM, Hagen P-O (1987) Verapamil therapy reduces intimal hyperplasia in balloon-injured rabbit aorta. Circulation 76(suppl):314.Google Scholar
- 5.Sugano M, Nakashima Y, Matushima T (1986) Suppression of atherosclerosis in cholesterol-fed rabbits by dilitiazem injection. Atherosclerosis 6:237–241.Google Scholar
- 11.Umeda T, Naomi S, Iwaoka D, Inoue J, Ohno M, Hamazaki S, Miura F, Sato T (1986) The antihypertensive effect and pharmacokinetics of nilvadipine(FK235) in essential hypertension. Jpn J Clin Pharmacol Ther 17:735–748.Google Scholar
- 12.Ohtsuka M, Ono T, Shibayama F (1988) Nilvadipine. Cardiovasc Drug Rev 6:97–115.Google Scholar
- 13.O-hara M, Esato K, Mohri H (1988) Effect of pancreatopeptidase E (Elastase) on the suppression of intimal fibrous proliferation after arterial reconstruction in high cholesterol fed rabbits. J Cardiovasc Surg 29:268–276.Google Scholar
- 16.Ross R (1986) The pathogenesis of atherosclerosis—an update. N Engl J Med 20:488–500.Google Scholar
- 23.Mutoh S, Nomoto A, Hirosumi J, Sekiguchi C, Yamaguchi I, Aoki H (1987) Antiatherogenic activity of FR34235(Nilvadipine), a new potent calcium antagonist: Effect on cuff-induced intimal thickening of rabbit carotid artery (Japanese). Domyakukoka 15:115–120.Google Scholar
- 27.El-Sanadiki MN, Cross KS, Murray JJ, Schuman RW, Mikat E, McCann RL, Hagen P (1989) Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment. Ann Surg 212:87–96.Google Scholar
- 28.Groves HM, Kinlough-Rathbone RL, Mustard JF (1986) Development of non-thrombogenicity of injured rabbit aortas despite inhibition of platelet adherence. Atherosclerosis 6:189–195.Google Scholar
- 31.Horiuchi I, Kawamoto T, Okamoto M, Ohshima T, Takizawa I, Kawakami M, Maruhashi A, Kanazawa I, Sasaki H, Kubota S, Okuhara T, Mitsuda H, Oyamada K, Fujiyama M, Yamada K, Yokote Y, Fujii H, Kido K, Kajiyama G (1986) Effect of nilvadipine treatment on lipoprotein metabolism and hypertension (Japanese). Geriat Med 24:1671–1679.Google Scholar